Criteria for validating mouse models of psychiatric diseases - Wikidata - wikimedia - TriplyDB

Criteria for validating mouse models of psychiatric diseases

Criteria for validating mouse models of psychiatric diseases

http://www.wikidata.org/entity/Q30480118

about

Exploring the Validity of Valproic Acid Animal Model of Autism Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders Impact of Low-Dose Oral Exposure to Bisphenol A (BPA) on Juvenile and Adult Rat Exploratory and Anxiety Behavior: A CLARITY-BPA Consortium Study.Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.Animal models of neuropsychiatric disorders Mouse Model of Neurological Complications Resulting from Encephalitic Alphavirus Infection.Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome.Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders.Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders New frontiers in animal research of psychiatric illness Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice.A quantitative analysis of the effects of qualitatively different reinforcers on fixed ratio responding in inbred strains of mice.Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications.The touchscreen operant platform for assessing executive function in rats and mice.Social peers rescue autism-relevant sociability deficits in adolescent mice.Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective Chronic sleep restriction during development can lead to long-lasting behavioral effects Comparison of Neurological Function in Males and Females from Two Substrains of C57BL/6 Mice.Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin.Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease.Molecular and cellular mechanisms of learning disabilities: a focus on NF1.Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia Functional enrichment analysis with structural variants: pitfalls and strategies.Evaluating the links between schizophrenia and sleep and circadian rhythm disruption.A mouse model for too much TV?Modelling the genetic contribution to mental illness: a timely end for the psychiatric rodent?Microglia: Architects of the Developing Nervous System.Modelling depression in animals: at the interface of reward and stress pathways.Interaction of bisphenol A (BPA) and soy phytoestrogens on sexually dimorphic sociosexual behaviors in male and female rats.Therapy for hyperthermia-induced seizures in Scn1a mutant rats.Hippocampal dysfunction in the Euchromatin histone methyltransferase 1 heterozygous knockout mouse model for Kleefstra syndrome.The effects of native whey and α-lactalbumin on the social and individual behaviour of C57BL/6J mice.Animal models for autism in 2017 and the consequential implications to drug discovery.Animal Models in Translational Research: Rosetta Stone or Stumbling Block?Large-scale objective association of mouse phenotypes with human symptoms through structural variation identified in patients with developmental disorders.Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory.Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.Distinct Phenotypes of Mouse Models Reflect Neuropsychiatric Spectrum Disorders of Human Patients With Variants

P2860

Q26771764-64B84804-7615-4942-A24C-D9519B6D3010 Q28086930-64AE62C1-ABFC-447F-B8B2-8F525CA1652A Q28396646-7881531B-4C5B-484F-A662-4837201F5534 Q29618411-81DE2A99-10A6-421E-BCD8-D4D003FBB77B Q29619899-31B262DB-BC1D-4686-8888-ABB930620A27 Q30362938-B3B8D5A5-ACDA-4A3D-9358-F4F3913AB77D Q30367333-69367DBB-E15F-4C79-9879-F3CFEEEDBCFA Q30451842-48B897CD-F02E-4172-8087-12D671505245 Q30458768-69F34B16-94D6-4F96-9DA4-42BB0112D379 Q30468290-CC083CE6-8E55-4608-B0FE-230BD57F34C1 Q30501284-C1A9487D-A3AB-4D2E-9BA4-215547E1B359 Q30539665-4D1D1048-BFB3-4AD5-B9E3-106CBB5BCC8A Q33968713-0A75075E-4326-47BC-81BC-CDC6ACA82B78 Q34040442-D856C41C-48CC-47FF-8CDE-EC8E76E31AD9 Q34730502-E3C6C699-8508-4A48-B88F-8C9596B00480 Q36275707-6AF63535-319D-4022-9788-7AB9E2764448 Q36386410-C6FC964B-8F2D-48DA-830C-A769A020D2EC Q36485422-E4BBF81D-31B6-437E-8D87-303256835B71 Q36791749-30F3664E-64B6-4406-B051-404D03E592E5 Q36941359-CDDC9A30-FFA5-4E4A-A4C1-71C5DEDA674D Q37717405-7AEE0EB0-2130-4A63-BFC7-D90C720D47FF Q37719525-4530978E-5BC5-4D74-8D4B-35D316B045E0 Q37780606-1CA7A510-AFCD-46BD-82B2-210FD736D79C Q37846896-8435F643-E7C7-48BD-B518-E59C2EA44D31 Q37945467-A192A278-1B9B-419E-B4EB-66D63D6FB025 Q38008577-51E8247B-A1E2-45CB-86F3-4A2D5B3B328B Q38045512-8EAC7E83-7596-4705-B02B-081BFB4F2905 Q38214995-EFDE0332-D3F0-414D-B661-19ED47C2D9F2 Q38785333-2E823D78-990A-48E6-9EB6-8592B482B2E3 Q39146103-F8B60F46-FE4A-492E-86A3-BF4EAE3A9A85 Q39635737-A3DBC02B-B808-4161-BA73-5B959CBDA25A Q40328281-00D2782F-7364-4693-A374-EFA126A02946 Q42516528-DAC8AA75-5CA1-4402-B02F-780EA395F933 Q46614078-BCB609FA-89E6-4EE9-AA14-BDA38A946674 Q47668964-FCFF33EE-5BB9-41B6-A6FB-31326A2FD4E4 Q50101264-725C42A7-0CAF-44E1-B859-0146DC04418B Q51806881-5E219A82-3F42-439E-82C5-372316C5A3EB Q53828453-155716CF-2C3E-487C-AD83-792AFA535FD1 Q55180784-B0E2ECDD-C752-4ED0-A82E-1D494AD6EB5D Q57175338-3800FC25-B97E-4F41-83E7-3F4718D22D19

P2860

Criteria for validating mouse models of psychiatric diseases

http://www.wikidata.org/entity/Q30480118

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Criteria for validating mouse models of psychiatric diseases

@ast

Criteria for validating mouse models of psychiatric diseases

@en

type

label

Criteria for validating mouse models of psychiatric diseases

@ast

Criteria for validating mouse models of psychiatric diseases

@en

prefLabel

Criteria for validating mouse models of psychiatric diseases

@ast

Criteria for validating mouse models of psychiatric diseases

@en

P1433

Q30480118-5BE1ABA1-D725-4B11-9C24-9D726124129A

P1476

Q30480118-604F2B42-B814-4B7C-BC3E-93A7248D95F8

P2093

Q30480118-5A04012E-6E58-419B-9875-8267F6CFF9B8

Q30480118-6C05E594-C320-4568-ADAF-49F0FEC2D557

Q30480118-D86AF2FC-1A99-47BE-AD8E-D8C02E3DAB8B

P2860

Q30480118-0270DDAC-4797-4986-8DA8-9E01B8F896E8

Q30480118-0357B514-489B-4723-9457-708BACFB8FDE

Q30480118-03B78048-6E4C-40B4-9A0B-1394FC1A8599

Q30480118-044E6B88-CCBF-4D38-9D89-E76ECF67015E

Q30480118-04B37FF4-68AF-4FD7-B873-9F364786F340

Q30480118-1726E37E-9072-471E-943A-4DB5261C59D2

Q30480118-1976B3ED-11E0-4193-BEA1-FB7BC7566365

Q30480118-1B626FC4-6AA9-480D-BD9A-EA44F7C49A4B

Q30480118-1ECCDCF5-5AAC-4B99-B358-E90616D1E728

Q30480118-2011BC4C-F973-44D8-8B48-8ED1B8D803A8

P304

Q30480118-9198C371-4BD7-4ABE-8433-12EB8EA18B4F

P31

Q30480118-059FBE72-4CDE-4D11-BFBE-261A3B94D544

P356

Q30480118-BE3B9DE7-B32A-45B1-A99F-1D828FED00F7

P433

Q30480118-99BC67B7-DB99-4979-A71C-9FF7DC84B1AB

P478

Q30480118-94538D1E-E1BC-4AC4-B00C-E656DE2197E5

P577

Q30480118-F4F5BD43-382D-4E55-AD98-9D43EFB9F634

P5875

Q30480118-A3D5D7FB-54A5-409A-90C6-EE196D44F5B0

P698

Q30480118-81008D9C-DE92-4E04-A63A-471E0F9B2359

P932

Q30480118-3D2A18FD-42F1-44FB-9F24-A2A1B16D5AC2

P356

P1433

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

P1476

Criteria for validating mouse models of psychiatric diseases

@en

P2093

Jacqueline N Crawley

http://www.w3.org/2001/XMLSchema#string

Kathryn K Chadman

http://www.w3.org/2001/XMLSchema#string

Mu Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Neural consequences of environmental enrichment

Genetics of age-related hearing loss in mice. III. Susceptibility of inbred and F1 hybrid strains to noise-induced hearing loss

RIGUI, a putative mammalian ortholog of the Drosophila period gene

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

Role of the CLOCK protein in the mammalian circadian mechanism

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

Inbred strain differences in prepulse inhibition of the mouse startle response

Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior

Behavioral despair in mice: a primary screening test for antidepressants

Forced swimming test in mice: a review of antidepressant activity

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.B.30777

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

150B

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5366734

http://www.w3.org/2001/XMLSchema#string

P698

18484083

http://www.w3.org/2001/XMLSchema#string

P932

2914616

http://www.w3.org/2001/XMLSchema#string